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We have studied cardiac and respiratory functions of aquaporin-1-deficient mice
by the Pressure-Volume-loop technique and by blood gas analysis. In addition, the
morphological properties of the animals’ hearts were analyzed. In anesthesia under
maximal dobutamine stimulation, the mice exhibit a moderately elevated heart rate
of <600 min−1 and an O2 consumption of ∼0.6 ml/min/g, which is about twice the
basal rate. In this state, which is similar to the resting state of the conscious animal, all
cardiac functions including stroke volume and cardiac output exhibited resting values
and were identical between deficient and wildtype animals. Likewise, pulmonary and
peripheral exchange of O2 and CO2 were normal. In contrast, several morphological
parameters of the heart tissue of deficient mice were altered: (1) left ventricular wall
thickness was reduced by 12%, (2) left ventricular mass, normalized to tibia length,
was reduced by 10–20%, (3) cardiac muscle fiber cross sectional area was decreased
by 17%, and (4) capillary density was diminished by 10%. As the P-V-loop technique
yielded normal end-diastolic and end-systolic left ventricular volumes, the deficient hearts
are characterized by thin ventricular walls in combination with normal intraventricular
volumes. The aquaporin-1-deficient heart thus seems to be at a disadvantage compared
to the wild-type heart by a reduced left-ventricular wall thickness and an increased
diffusion distance between blood capillaries and muscle mitochondria. While under the
present quasi-resting conditions these morphological alterations have no consequences
for cardiac function, we expect that the deficient hearts will show a reduced maximal
cardiac output.
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INTRODUCTION
AQP1 has first been reported to act as a membrane water channel by Preston et al.
(1992), replacing the long-standing idea that water passes biological membranes
through their lipid phases. Later on, several additional functions of AQP1 have been
established, among them its function as a channel for CO2 (Nakhoul et al., 1998;
Endeward et al., 2006) and for NH3 (Nakhoul et al., 2001; Musa-Aziz et al., 2009).
Al-Samir et al. Cardiac and Respiratory Functions in AQP1-Deficient Mice
Moreover, permeabilities of the AQP1 channel have been
postulated for hydrogen peroxide (Almasalmeh et al., 2014), for
nitric oxide (Herrera et al., 2006), and for oxygen (Wang et al.,
2007). During the last 10 years, evidence has been accumulated
that AQP1 plays a crucial role in angiogenesis and in general in
cell migration (Saadoun et al., 2005).
The present study was prompted by three recent observations:
(a) Montiel et al. (2014) reported a reduced weight of the hearts
of AQP1-deficient mice compared to normal mice; (b) it has
been reported that the spontaneous physical activity of AQP1-
deficient mice on running wheels is 40% lower than that of
WT mice (Boron, 2010); (c) we have observed that the maximal
metabolic rate of AQP1-knockout mice is significantly lower in
AQP1-knockout than in WT mice (Al-Samir et al., submitted
for publication). We have asked therefore, whether a reduced
cardiac output could be the consequence of observation a and
cause observations b and c. We have therefore undertaken
the following measurements on the hearts of AQP1-deficient
mice:
(1) We studied for the first time cardiac function of AQP1-KO
and WT mice by the P-V loop technique. This had to be
done in anesthesia implying that hearts were not maximally
activated and results were largely representative of animals’
resting conditions.
(2) Furthermore, we performed a detailed study of the
morphology of the hearts of these mice, with the intention
to see whether their morphology suggests restraints imposed
on maximal cardiac performance.
(3) In addition we present for the first time comprehensive
blood gas data characterizing pulmonary and peripheral
gas exchange in these mice under anesthesia, i.e., under
conditions close to resting conditions. This was expected
to indicate whether lack of AQP1 leads to a functionally
significant impairment of pulmonary or peripheral gas
exchange under resting conditions.
The major findings of this paper are, firstly, that AQP1-deficient
mice have thinner ventricle walls and poorer capillarisation
of cardiac muscle than normal mice. Secondly, the AQP1-
deficient mice exhibit normal cardiac functions, e.g., normal
stroke volume and cardiac output. Thirdly, these animals show,
under the conditions just mentioned, normal pulmonary, and
peripheral exchange of O2 and CO2. The second and third groups
of findings explain why the AQP1-KO animals under laboratory
conditions show no pathological cardiac or respiratory symptoms
whatsoever.
However, the thin ventricle walls that go along with a
reduced cardiac muscle mass suggest that under conditions of
maximal workload these hearts will generate a reduced cardiac
output compared to wildtype hearts. Thus, maximal exercise
capacity of the KO animals is expected to be reduced. Regarding
the cause of the reduced cardiac muscle mass, we speculate
that lack of AQP1 leads to a reduced capillarisation and that
this causes an inhibition of the growth of cardiac muscle
fibers.
METHODS
Animals and Pressure-Volume Loop
Measurements
Breeding pairs of heterozygous aquaporin-1 ko mice were kindly
provided by Dr. Alan S. Verkman (San Francisco, USA; Ma et al.,
1998; mice bred on a BL6 background). They were intercrossed to
obtain homozygous AQP1-KOmice andWT littermate controls,
as ascertained by PCR genotyping using the DNA from tail
snippets and specific primers (AAG TCA ACC TCT GCT CAG
CTG GG for AQP1-WT, CTC TAT GGC TTC TGA GGC GGA
AAG for AQP1 Neo, and ACT CAG TGG CTA ACA ACA AAC
AGG for AQP1-KO, in one single PCR reaction). The mice used
in the study had an average age of 18 weeks (SD ± 4.7, n = 14).
Male and female groups were age-matched.
In vivo pressure-volume (P-V) loop measurements
were conducted under 2% isoflurane anesthesia. A 1.4 F
micromanometer conductance catheter (SPR-839, Millar
Instruments, Houston, TX) was inserted via the right carotid
artery and steady-state P-V loops were sampled at a rate of 1
kHz. In each animal, P-V loops were measured sequentially
under infusion via a second catheter inserted into the jugular
vein of 0, 2.5, 5, 10, 20, and 40 ng dobutamine/g body
weight/min (every dose for 3 min). P-V loops were analyzed by
a sample-blinded investigator (Y.W). At the end of the P-V loop
recordings, and immediately after a final infusion pulse of 40 ng
dobutamine/g/min, left and right ventricle were punctured to
obtain arterial and mixed-venous blood gas samples. Animals
were immediately killed thereafter and organs were harvested
for further analysis. All animal procedures were approved by the
local state authorities.
Blood Gas Analyses
0.3 ml blood samples were taken by puncture from each LV
and RV of all mice used for P-V loop measurements. This was
done immediately before termination of the animal experiment
and under final stimulation by a repeated infusion of 40 ng
dobutamine/g/min. Heparine was present in the syringes to
suppress coagulation. These samples were analyzed twice in
a Radiometer ABL805 Flex blood gas analyser (Radiometer,
Willich, Germany) at 37◦C for pH, pO2, pCO2, hemoglobin
concentration cHb, and oxygen saturation SO2, base excess ABE,
as well as lactate and glucose concentrations.
Histology
Left ventricles were cut out from mouse hearts removed
after termination of the P-V loop experiments, weighed, then
embedded in OCT compound (Tissue-Tek) and frozen at−80◦C.
Midventricular sections across the entire LV perpendicular to
the long axis were stained Masson’s trichrome staining and used
for determination of cardiac wall thickness by measuring and
averaging the thicknesses of the folds of the LV sections.
For fluorescent (immuno)staining, midventricular slices of
the left ventricle were embedded in OCT compound and frozen
at −80◦C. Five micrometer thick cryosections were stained
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with TRITC-conjugated wheat germ agglutinin (WGA, Sigma-
Aldrich) to outline cardiomyocytes. The circumferences of>700
myocytes per LV were traced and digitized to calculate mean
cardiomyocyte cross-sectional area. Only cells from fields with
circular myocyte shapes (indicative of a transverse section)
were analyzed. Fluorescein-labeled GSL I-isolectin B4 (Vector
Laboratories, Burlingame, CA) was used to visualize capillaries.
Density of cardiomyocyte fibers and of capillaries were counted
in about 12 randomly selected areas of 0.03695 mm2 of each LV.
Images were acquired with an Axiovert microscope (Carl Zeiss,
Jena, Germany).
Quantitative Real-Time PCR (qPCR)
Total RNA was extracted from LV myocardium by TRIzol
(Invitrogen) and purified with RNeasy kits (Qiagen, Hilden,
Germany). After reverse Transcription (Superscript II,
Invitrogen), qPCR of α-MHC (myosin heavy chain), and
β-MHC mRNA and SERCA (sarco-endoplasmic reticulum
Ca++-ATPase) mRNA were performed using the brilliant SYBR
Green Mastermix-Kit and the MX4000 multiplex QPCR System
from Stratagene. Details as published previously (Korf-Klingebiel
et al., 2011).
GAPDH- and PDK1-transcript levels were analyzed on
a Rotor-Gene 2000 real-time PCR thermocycler (Qiagen,
Hilden, Germany) using Power SYBR Green Supermix
(Applied Biosystems, Darmstadt, Germany) according to
the manufacturer’s instructions. Data were quantified using
Rotor-Gene Q Series Software 1.7 (Qiagen). Efficiencies were
calculated from the slope of template dilution curves with
primers for genes of interest and the reference gene (Rps12),
and used for quantification of changes of transcript levels by the
11Ct-method. The efficiency of all primer sets was between 95
and 105%. Data were presented as mean ± SE and analyzed by
student t-test. Primer pairs used were:
Glyceraldehyde-3-phosphate dehydrogenase (Gapdh;
GenBank accession no. NM_001289726.1): forward primer:
5′-TGT GTC CGT CGT GGA TCT GA-3′; reverse primer:
5′-CCT GCT TCA CCA CCT TCT TGA-3′.
Pyruvate dehydrogenase kinase 1 (Pdk1; GenBank accession
no. NM_172665.5): forward primer: 5′-TGC TAC TCA ACC
AGC ACT CC-3′; reverse primer: 5′-TTA ATG ACC TCC ACC
ACG TC-3′.
Ribosomal protein S12 (Rps12; GenBank accession no.
NM_011295.6): forward primer: 5′-AAG GCA TAG CTG CTG
GAG GTG TAA-3′; reverse primer: 5′-AGT TGG ATG CGA
GCA CAC ACA GAT-3′.
RESULTS
Body and Organ Weights
Figure 1 shows body weights and lung and left ventricular
weights from seven wild-type (WT) and seven knockout (KO)
mice systemically deficient in AQP1. Each group of mice had
three males and four females. It is apparent that body weights
are moderately but significantly reduced in the deficient mice,
by 6% in males and by 12% in females. Left ventricular weights
in Figure 1 were normalized for tibia length; they are reduced
in deficient mice by 20% for males, and by 8% for females.
FIGURE 1 | Body weights (A), lung weights (B), and left ventricular (LV)
weights normalized for tibia length (C), for the animals used in the P-V
loop measurements. Sexes are considered separately, and body weights as
well as LV weights show significant differences between WT and KO animals
for each sex. In the case of LV weights, the significance remains, when sexes
are combined. n = 7 for both sexes together. * indicates statistically significant
difference between KO and WT values.
Weights of left ventricles (LV) are also reduced in deficient vs.
WT mice when not normalized. When normalized for body
weight, the differences are present but do not reach statistical
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significance when the sexes are considered separately. When the
sexes are combined, both LV weight per body weight and LV
weight per tibia length are significantly lower in deficient vs.
WT mice. Thus, there is clear evidence that LV from AQP1-
KO mice exhibit a lower weight than those from WT mice.
Figure 1 shows in addition, that neither in males nor in females
lung weights are affected by the knockout of AQP1. The results
of Figure 1 show that the consequences of AQP1-knockout are
fundamentally identical inmales and females. This holds true also
for all other parameters considered in this paper and prompted us
in the following to generally consider the combined results from
females and males.
Left Ventricular Wall Thickness of
AQP1-Deficient Mice
Figure 2 shows examples of cross sections of left ventricles of
WT and AQP1-KO, which seem to suggest a somewhat thinner
wall in the knockout heart. This has been confirmed by an
analysis of heart wall thickness in 6 WT and 6 KO hearts
(Table 1). Altogether 54 and 50 wall thickness measurements
were performed in WT and KO hearts, respectively. We obtain
a wall thickness of 1.37 mm (SE ± 0.03 mm) in WT hearts,
and of 1.22 mm (SE ± 0.02 mm) in AQP1-KO hearts. The
difference between these values is highly significant (P< 0.0001).
We conclude that knockout left ventricles exhibit a∼12% thinner
wall than WT left ventricles. It appears then that the reduced
LV weight of KO hearts is partly or entirely due to a reduced
thickness of LV walls.
Cardiac Muscle Fibers and Capillaries in
AQP1-Deficient Mice
Figures 3A,B show examples of muscle fiber staining,
Figures 3C,D of capillary staining, and Figures 3E,F show
overlays of fiber and capillary staining of WT and KO LV muscle
tissue, respectively. Although differences between WT and
KO staining patterns are not readily recognizable from these
figures, a detailed analysis yields marked differences in several
parameters related to muscle fibers and capillaries, as seen in
Table 1. The average cross sectional area of WT cardiomyocyte
fibers from the left ventricle is 325 µm2 (SE ± 2 µm2), while
this value is reduced by 15% to 277 µm2 (SE ± 2 µm2) in
FIGURE 2 | Heart cross sections, taken perpendicular to the
longitudinal heart axis, and stained with Masson’s trichrome staining.
Animals are those used in the P-V loop measurements. Bar 1 mm.
AQP1-KO hearts (P < 0.0001). In correspondence with this,
the density of the muscle fibers is increased from 3088 mm−2
(SE ± 58 mm−2) in WT to 3327 mm−2 (SE ± 81 mm−2) in
AQP1-KO mice (P = 0.017). Although the number of fibers per
area is thus increased by 8% in KO, the number of capillaries
per tissue area is decreased by 9%: 3097 capillaries per mm2
(SE ± 46 mm−2) in WT fall to 2827 mm−2 (SE ± 49 mm−2)
in KO hearts (P = 0.0001). As a consequence of this, the
capillary to fiber ratio is 1.01 (SE ± 0.03) in WT and is reduced
by 15% to 0.86 (SE ± 0.04) in AQP1-KO hearts (P = 0.02).
In summary, the AQP1-KO left ventricles exhibit a reduced
muscle fiber thickness in conjunction with an increased fiber
density. The latter is associated with a decreased capillary
density.
Cardiac Function in AQP1-Deficient Hearts
These studies were essentially obtained by the steady-state
LV pressure-volume loop technique. Parameters shown in
Figures 4A,B were determined at various infusion rates of
dobutamine between 0 and 40 ng/g/min. All parameters
given in Figure 4 exhibit no significant difference between
WT and AQP1-KO, when subjected to two-way repeated
measures ANOVA (Prism 6, GraphPad Software, La Jolla,
USA; 2015). This holds, firstly, for the basic functional
parameters stroke volume, heart frequency and, consequently,
cardiac output. It may be noted that heart rate, even under
near-maximal dobutamine stimulation at 40 ng/g/min, does
not exceed ∼550–600/min (Figure 4A, 1st row, right panel).
Under anesthesia, and without cardiac stimulation, heart rates
are ∼450–500/min, which agrees roughly with the heart
rates of ∼430/min reported for anesthetized mice without
dobutamine stimulation (Hoit et al., 2002). It is noteworthy
that, similarly, end-systolic as well as end-diastolic LV volumes
and pressures are not different between WT and AQP1-KO
hearts, and are influenced by dobutamine in comparable ways
(Figures 4A,B). It follows that the ejection fraction of the left
ventricle is also identical between WT and AQP1-deficient
hearts. Likewise, Figure 4B shows that dP/dtmax and dP/dtmin
are not significantly different in WT and AQP1-deficient
hearts.
In conclusion, under conditions of anesthesia without as well
as with moderate stimulation of the hearts by dobutamine, all
functional parameters of AQP1-deficient hearts are identical to
WT. The differences in muscle mass and wall thickness between
the two mouse types apparently do not affect the function of
moderately activated hearts.
Blood Gases and Oxygen Consumption of
Anesthetized AQP1-Deficient Mice
Table 2 shows that in arterial and venous pO2, SO2, pCO2,
pH and in base excess, there are no significant differences
between WT and AQP1-KO animals. All blood gas values
are in the normal range. Hemoglobin concentration of KO
mice is slightly but significantly lower than that of WT
mice (Table 3), which appears to be at variance with the
observation of Montiel et al. (2014), who report identical
hematocrits in both strains. Mean corpuscular volume, MCV,
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TABLE 1 | Morphological parameters of left ventricular cardiac muscle of hearts of WT and AQP1-KO mice.
WT (mean ± SE) KO (mean ± SE) n P
LV Wall Thickness (mm) 1.37± 0.03 1.22±0.02 54/50a < 0.0001
Muscle Fiber Cross Sectional Area (µm2) 325± 2 277±2 4392/4270b < 0.0001
Muscle Fiber Density (mm−2 ) 3088± 58 3327±81 72/70c 0.017
Capillary Density (mm−2) 3097± 46 2827±49 72/70c 0.0001
Ratio of Capillary to Muscle Fiber Density 1.01± 0.03 0.86±0.04 6d 0.02
aTotal number of wall thickness measurements from each group of six hearts, respectively.
bTotal number of fibers measured in the six hearts of each group.
cNumber of 0.03695 mm2 areas counted in cardiac tissue in each of the two groups of six hearts.
dRatio calculated from the mean values for each of six hearts per group.
FIGURE 3 | Sections prepared from cardiac tissue taken from the
animals used for PV-Loop measurements. (A,B) myofiber staining, (C,D)
capillary staining, (E,F) overlay of A,C, and B,D, respectively. A,C,E are from
WT hearts, B,D,F are from AQP1- KO hearts. Bar length 50 µm.
is found to be identical in WT and KO mice. Using the
arterio-venous SO2 differences from Table 2 together with
the respective blood hemoglobin concentrations, the cardiac
outputs from Figure 4A and the animals’ body weights, Table 3
presents the calculated specific oxygen consumptions of WT
and AQP1-KO mice under maximal dobutamine stimulation.
The values of 0.054 and 0.064 ml O2/min/g body weight
for WT and KO animals are not significantly different, but
are both a factor of 2 or a little less higher than the basal
O2 consumption of mice of ∼0.03 ml/min/g (Rosenmann
and Morrison, 1974). This difference is likely due to the
stimulatory effect of dobutamine on the animals in the present
experiment.
Expression of Some Functionally Relevant
Proteins in AQP1-Deficient Hearts
We have studied two HIF-dependent protein mRNAs to test
whether there is evidence for chronic hypoxia in AQP1-deficient
hearts. As seen in Figure 5, GAPDH as well as PDK1 mRNA
levels are identical in WT and KO hearts, giving no indication
of a hypoxic situation in this tissue. Another possible indicator
of pathological conditions in mammalian heart is the relation
between cardiac expression of α- vs. β-myosin heavy chains,
where a decrease in the α form together with an increase in the β
form is indicative of a number of pathological situations (Nakao
et al., 1997). Figure 5 shows that in the AQP1-deficient hearts
there are no significant differences in the expression of the two
myosin heavy chain isoforms to that observed in WT hearts.
Clearly, there is no increase in β-MHC expression in the KO
hearts.
In addition, we asked whether the diminished cardiac muscle
mass of KO mice might be functionally compensated by an
upregulation of sarcoendoplasmic reticulum ATPase (SERCA) in
cardiomyocytes. Figure 5 shows that this is not the case. Thus
the normal function of AQP1-deficient hearts is maintained by
another mechanism than increased expression of SERCA. This
latter finding is in agreement with the unaltered dP/dtmax of
AQP1-deficient hearts (Figure 4B).
DISCUSSION
Morphological Characteristics of the
AQP1-Deficient Mouse Heart
Two basic findings for AQP1-KO mice shown in Figure 1
confirm previous observations: body weight of AQP1-KO mice
is reduced by 6–12% compared to WT (Figure 1A). Similar
body weight reductions have been reported by Schnermann et al.
(1998). Also, left ventricular mass (normalized to tibia length) is
significantly reduced by 8–20% inmales and females (Figure 1C),
a finding qualitatively obtained also by Montiel et al. (2014). A
third result of the present paper, the reduced cardiac muscle fiber
cross sectional area in KO hearts (Table 1) that goes along with a
diminished heart muscle mass, has also been reported byMontiel
et al. (2014). However, three further findings of this study that are
of major functional importance and are shown in Table 1, have
not been reported before or are at variance with the observations
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FIGURE 4 | (A) Results from PV loop measurements, averaged from seven hearts from both female and male sexes. SV, stroke volume; HR, heart rate; CO, cardia
output; Ves, endsystolic volume; Ved, enddiastolic volume; EF, ejection fraction. Infusion of dobutamine was increased stepwise form 0 to 40 ng/g/min. Two-way
repeated measures ANOVA indicates no significant difference between curves, indicating that all parameters of WT and KO behave identically. (B) Results from PV
loop measurements, averaged from seven hearts from both female and male sexes. Pes, end-systolic pressure; Ped, end-diastolic pressure; dP/dt, maximal rate of
increase of LV pressure; dP/dt, maximal rate of relaxation of LV pressure. All pairs of curves are not significantly different when tested as described in panel (A).
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TABLE 2 | Blood gases of AQP1-deficient mice, under 40 ng/g/min
dobutamine.
KO ± SE WT ± SE nKO, nWT; P
1 pO2,a (mmHg) 378±16 404±4 6, 8; 0.16
2 pO2,v (mmHg) 42.5±2.7 48.0±1.4 6, 10; 0.193
3 1pO2, a-v (mmHg) 335±13 356±5 6, 8; 0.20
4 SO2,a% 100 100 9, 11;
5 SO2,v% 53.0±5.6 63.6±3.3 9, 11; 0.13
6 1SO2, a-v% 47.0±5.6 36.4±3.3 9, 11; 0.13
7 pCO2,a (mmHg) 20.1±0.9 20.7±1.1 7, 9; 0.66
8 pCO2,v (mmHg) 30.6±1.5 29.7±1.1 9, 10; 0.65
9 1pCO2, a-v (mmHg) −10.5±1.9 −8.9±1.3 7, 9; 0.25
10 pHa 7.34±0.017 7.35±0.021 7, 9; 0.80
11 pHv 7.26±0.031 7.29±0.022 9, 11; 0.39
12 1pH, a-v 0.08±0.03 0.06±0.02 9, 11; 0.18
13 ABE,a (mmol/l) −13.2±0.7 −12.8±1.1 8, 9; 0.79
14 ABE,v −12.3±1.0 −11.7±1.1 9, 11; 0.67
15 1 ABE, a-v −0.9±0.7 −1.1±1.2 9, 11; 0.68
pO2, pCO2 partial pressures of O2 and CO2 in blood; SO2 blood oxygen saturation;
ABE, actual base excess of blood. a, arterial; v, venous; ∆, arterio-venous differences;
KO, knockout mice; WT, wildtype mice; SE, standard error of the mean; n, number of
determinations. Blood samples were taken from the left and right ventricle, respectively,
under dobutamine stimulation at the end of the P-V loop measurements.
of Montiel et al. (2014): (1) the reduced LV wall thickness of
AQP1-deficient hearts, (2) the reduced capillary density in LV
muscle, and (3) the even more pronounced reduction of the
ratio capillary to muscle fiber density compared to WT hearts.
In contrast to findings (2) and (3), Montiel et al. (2014) have
reported an unaltered capillary to myocyte ratio, implying that,
like muscle fiber density, capillary density is even increased in
AQP1-KO hearts. The reason for the discrepancy is not clear.
In view of the present result of a reduced LV wall thickness,
we conclude that—at least the present—AQP1-deficient hearts
exhibit a reduced muscle mass in combination with thin ventricle
walls. In conjunction with the finding of normal end-diastolic
and end-systolic LV volumes as shown in Figure 4 and discussed
below, the emerging picture of the AQP1-deficient heart is that
of a heart of normal volume but reduced muscle mass due to
decreased thickness of ventricle walls. The underlying cause of
the reduced muscle mass may solely be the reduced muscle
fiber size (Table 1), while the total number of muscle fibers per
heart, although not known,may be normal.Whereasmuscle fiber
density is increased due to the fibers’ smaller size, the absolute
density of capillaries is reduced. This implies that the diffusion
distances for O2, substrates and metabolites are increased. In
summary, the AQP1-deficient heart seems to be at a disadvantage
compared to the WT heart due to its thinner ventricle walls
with diminished muscle mass and to its greater tissue diffusion
resistance toward O2.
Cardiac Function and Gas Exchange in
Anesthetized WT and KO Animals
In the following we will discuss the absolute values of cardiac and
respiratory parameters of anesthetized mice parameters and the
effects of dobutamine upon them.
TABLE 3 | Specific oxygen consumption of AQP1-KO and WT mice under
40 ng/g/min dobutamine.
Mean KO ± SE Mean WT ± SE nKO, nWT, P
CO (µl/min) 19.507±745 19.083± 858 6, 7; 0.72
1 SO2,a−v (%) 47.0±5.6 36.4± 3.3 9, 11; 0.13
cHb (g/100 ml) 11.9±0.2 12.9± 0.2 7, 6; 0.006
Body wt. (g) 22.9±1.2 25.2± 1.1 7, 7; 0.17
VO2,dob (ml/min/g) 0.064±0.012 0.054± 0.008 6, 6; 0.49
CO, cardiac output from P-V loop measurements; ∆ SO2,a−v , arterio-venous O2
saturation difference; cHb, blood hemoglobin concentration; VO2,dob, specific oxygen
consumption of whole animals under 40 ng/g/min dobutamine infusion, calculated from
the other parameters given in the table. KO and WT groups comprise both sexes. The
differences in body weights that are statistically significant when sexes are separated
(Figure 1), loose significance upon combining sexes, although still apparent. The VO2,dob
values shown are nearly a factor of two greater than the basal oxygen consumption of mice
of ca. 0.03–0.04 ml/min/g.
Cardiac Function
As apparent from Figure 4, none of the parameters obtained in
the P-V loop measurements was significantly different between
WT and KO mice. Some parameters clearly increase with
increasing dobutamine concentration, e.g., stroke volume (SV),
heart rate (HR), cardiac output (CO), end-diastolic volume
(Ved), and dP/dtmax. However these, as all other parameters,
depend on dobutamine in a manner indistinguishable between
WT and KO mice. We conclude that anesthetized KO mice,
even under dobutamine stimulation, exhibit an entirely normal
cardiac function. This holds in spite of the reduced cardiac
muscle mass and capillarisation as discussed above.
How do the numbers of Figure 4 compare to those
of conscious resting mice? With microsphere and dilution
techniques, Barbee et al. (1992) have obtained a heart rate of
652 min−1 for conscious mice in a state after recovery from
Avertin anesthesia and in conditions restraining their mobility.
Janssen et al. (2002) have reported a heart rate of 600 min−1
in conscious resting mice. Both figures are clearly higher than
our values obtained under anesthesia without as well as with
dobutamine stimulation (Figure 4A, 1st row, 2nd panel). It may
be noted that other authors report a resting heart rate of only
450–550min−1 in mice in a state after waking up from anesthesia
(Hoit and Walsh, 2002, p. 283; Kramer et al., 1993). No matter
whether we consider resting heart rate in conscious mice to be
652, 600, or 450–550 min−1, we can conclude that all heart rates
of anesthetized mice seen in Figure 4A, even in the presence of
the highest concentration of dobutamine, do not exceed the range
of values observed in conscious resting animals. Mice exercising
on a treadmill, on the other hand, reach heart rates up to about
800 min−1 (Hoit and Walsh, 2002, p. 284; Segrem and Hart,
1967; Kramer et al., 1993; Desai et al., 1997; Schuler et al., 2010,
and personal communication by Beat Schuler). So, dobutamine
in anesthetized mice does stimulate heart rate, but not to levels
outside the range of resting levels of conscious animals, and
its effect remains far below of what is seen in exercising mice.
The reason for this is the drastic depressive effect of anesthesia
on heart rate as demonstrated for example by Barbee et al.
(1992).
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FIGURE 5 | Analyses of transcripts from LV tissue of the WT and KO mice used in PV loop measurements. (A), mRNAs from two HIF-dependent enzymes
GAPDH and PDK1; (B), sarco-endoplasmic reticulum Ca++-ATPase; (C), α- and β-myosin heavy chain mRNAs.
Likewise, the stroke volumes seen in Figure 4A are similar to
the value of ∼30 µl reported for the resting mouse by Janssen
et al. (2002). Also the cardiac outputs seen in Figure 4A are all in
the range of values reported for the resting mouse, 16 ml/min by
Barbee et al. (1992) and 20ml/min by Janssen et al. (2002). Again,
dobutamine does not raise these parameters to levels above the
range of resting values in unanesthetized mice. In conclusion, all
three cardiac parameters in this study remain under anesthesia
in the range of resting values of conscious resting animals even
when dobutamine stimulation is applied.
Blood Gases
All values of Table 2 are similar to what is expected for humans
and other mammals respiring 95% O2/5% CO2. As in the case
of the parameters of cardiac function, there are no significant
differences in blood gas values of anesthetized dobutamine-
treated WT vs. KO animals (Table 2). Specifically, arterial pO2
and SO2 are identical in both types of animals, suggesting that
pulmonary O2 exchange is not affected by the lack of AQP1. It
should be noted that the high inspiratory pO2 (corresponding to
95% O2) can render a moderate pulmonary diffusion problem
or an unequal distribution of ventilation/perfusion invisible in
terms of their effect on SO2, but their effect on pO2,a might
remain visible. In addition, mixed venous pO2 and SO2 are not
significantly different, suggesting that peripheral O2 exchange is
also unaffected. However, in both independent measurements
of pO2,v and SO2,v there is a tendency toward lower values in
KO compared to WT animals. It may be speculated that this
points to a need for enhanced O2 extraction in the periphery
of KO animals, which would be necessary when either VO2 is
higher and/or CO is lower in KO than in WT animals, two
possibilities we can both exclude under resting conditions on
the basis of the present data (Table 3, Figure 4). Clearly, this
finding excludes a markedly increased resistance for transfer of
O2 from blood to tissues in animals lacking AQP1, because this
would be expected to lead to rather enhanced values of pO2,v and
SO2,v. An identical conclusion is arrived at when considering
the exchange of CO2. Arterial pCO2 is identical between KO
and WT animals, and likewise mixed venous pCO2 values are
identical. This suggests that pulmonary as well as peripheral CO2
exchange is unaffected by the absence of AQP1 in animals under
“resting conditions”. It may be noted that Yang et al. (2000) and
Swenson et al. (2002) in studies of pulmonary CO2 exchange
under “resting conditions” also found no evidence for a role of
aquaporin.
Oxygen Consumption
Table 3 shows that, firstly, oxygen consumption of anesthetized
mice at maximal dobutamine stimulation is around 0.06
ml/min/g. This is twice or a little less the basal oxygen
consumption of mice of 0.03–0.04 ml/min/g (Hoit and Walsh,
2002, p. 285 Segrem and Hart, 1967; Rosenmann and Morrison,
1974; Heldmaier and Neuweiler, 2004). This slightly elevated
level is likely due to the maximal dobutamine stimulation
prevailing when the parameters cardiac output and blood oxygen
saturation, which are used to calculate VO2, are measured here.
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This is in agreement with the observation of Rosenmann and
Morrison (1974) on the effect of adrenergic stimulation on VO2
of mice. Secondly, Table 3 shows that, at this moderately elevated
level of VO2, aquaporin-1 deficiency has no significant effect
on VO2. Since conscious mice due to their normal level of
physical activity will exhibit a similar VO2 (=“resting VO2”;
Segrem and Hart, 1967; and own unpublished observations),
we can expect that AQP1-deficient laboratory mice moving
normally in their cages will have no limitation of oxygen
supply.
Summary of Cardiac and Respiratory Functions in
Anesthetized AQP1-KO Mice
Although AQP1 is present in capillaries of most tissues such
as skeletal and cardiac muscle and the lung (Nielsen et al.,
1993; Verkman, 2007; Rutkovskiy et al., 2013), the present data
indicate that it does not affect O2 and CO2 exchange in these
organs under conditions of moderate VO2. It should be noted
that in skeletal and heart muscle and in the lung other AQP
isoforms are strongly expressed, AQP4 in the plasma membranes
of skeletal and cardiac myocytes and AQP5 in the plasma
membrane of alveolar epithelia (Verkman, 2007; Rutkovskiy
et al., 2013). Both AQP5 and AQP4 are similarly good conductors
of CO2 as AQP1 (Musa-Aziz et al., 2009) and might substitute
for AQP1 in its possible role in gas transfer. Additionally
we have shown previously that a role of gas channels in gas
transfer would become apparent only under maximal workload
and metabolism but not under resting conditions (Endeward
et al., 2014). In the lung, for example, this implies that at
rest and moderate workload CO2 exchange remains perfusion-
limited, and becomes diffusion-limited only under conditions of
maximal exercise (Endeward et al., 2008). Thus, it is in line with
these previous studies that in this paper we find no indication
of an altered gas exchange in anesthetized AQP1-deficient
animals.
Similarly, we find here that cardiac function under the
present conditions of moderately elevated VO2 is normal. This
may seem surprising in view of the thinner LV walls and
the reduced cardiac muscle mass in AQP1-KO animals. We
propose that this may result from a compensation mediated by
the Frank-Starling mechanism. Thinner walls will be associated
with an increased compliance 1V/1P of the ventricle. Indeed,
end-diastolic volume/end-diastolic pressure is on average 4.2
µl/mmHg for KO hearts and 3.7 µl/mmHg for WT hearts
in the absence of dobutamine, indicating a greater ventricular
compliance in KO hearts, although the above difference does
not reach statistical significance. When compliances are different
and intraventricular pressures are identical between WT and KO
mice, as apparent from Figure 4, the tension and length of the
individual muscle fibers are expected to be greater in KO than in
WT hearts. Thus, although KO hearts possess less muscle mass,
their force production may be equal to WT hearts because of the
increased strain of their fibers. This would explain the normal
stroke volume generated by KO hearts under resting conditions.
An analogous conclusion is arrived at by considering Laplace’s
law.While this mechanism obviously is able tomaintain a normal
heart function at moderate workloads, it must be expected that
the KO heart will exhibit a diminished maximal performance at
very high workloads. In this context, it is noteworthy that Boron
(2010) has observed that AQP1-KO mice exhibit a 40% reduced
spontaneous physical activity on a running wheel compared to
WT mice.
Figure 5 strongly supports this view of an entirely normal
heart function in AQP1-KO mice under the conditions they are
kept at in the laboratory. The unaltered expression of the mRNA
of HIF-dependent enzymes GAPDH and PDK1 suggests that
there is no tissue hypoxia in the heart under the conditions of
the minor physical activity mice exhibit in their cages. Similarly,
the ratio of α- to β-MHC is unaltered, so this again does not
suggest a pathological condition of the heart. Lastly, there is
clearly no up-regulation of cardiac SERCA, which could occur
in an attempt to increase the contractility of the reduced total
muscle cross-sectional area of KO hearts. All three parameters
give no indication of pathological conditions or adaptations
to pathological conditions that could be envisaged in these
hearts. We conclude that AQP1-KOmouse hearts under “resting
conditions” seem to be entirely up to their tasks. Limitations
are only expected to become apparent under conditions of
maximal workloads that do not occur under normal conditions
in laboratory mice.
It may be noted that in the case of AQP1-deficient humans
neither size and wall thickness of the hearts have been described,
nor have results of exercise testing of these patients been reported
(King et al., 2001; Verkman, 2008).
A Possible Cause of the Diminished
Muscle Mass of AQP1-Deficient Hearts
The major morphological alterations of the AQP1-deficient heart
that have been described in this study are: reduced cardiac
muscle mass, reduced LV wall thickness, reduced cross-sectional
area of ventricular myofibers, reduced ratio of capillaries
to myofibers, and reduced absolute density of capillaries in
LV tissue. Is there one underlying primary mechanism that
leads to these alterations? We have no experimental evidence
on such a mechanism, but we can speculate on the basis
of two established properties of AQP1 as mentioned above,
that of a gas channel and that of an essential element
in angiogenesis.
If cardiac tissue is deprived of a channel for CO2, possibly
also for O2, could some of the morphological alterations just
listed be envisaged as direct consequences? If the diffusion
resistance of the capillary wall (and the sarcolemma) for O2/CO2
is increased due to the lack of AQP1, the only possible adaptation
during heart development would seem to be an increase in
capillary density, which would reduce the diffusion distances
and thus compensate for the increase of membrane resistances
toward CO2/O2. Table 1 shows that these hearts instead show a
decrease in capillary density, which will even impair gas diffusion
between capillaries and muscle mitochondria. Thus, it appears
unlikely that the observation of Table 1 represents a direct
consequence of the lack of AQP1 in its function as a CO2/O2
channel.
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A distinct deviation of the present results from those of
Montiel et al. (2014) is our observation of a reduced capillary
density in heart muscle. This opens up the possibility that
the reduced size of left ventricular cardiomyocytes and wall
thickness is the direct consequence of an impaired capillarisation
due to the absence of AQP1. We will discuss two possible
mechanisms that could link capillarisation to the expression
of AQP1.
Firstly, as stated above, another gas proposed to be conducted
by AQP1 is NO (Herrera et al., 2006; Herrera and Garvin, 2007).
These authors have shown NO flux out of endothelial cells and
into smooth muscle cells to occur via AQP1. Furthermore, they
have reported that NO-dependent relaxation in thoracic aortas
is impaired in AQP1-KO mice, although this latter finding has
not been confirmed by Montiel et al. (2014). Since NO has been
shown to play a central role in vascular development (Yuan
and Kevil, 2016), it would be conceivable that these effects of
NO are also mediated by AQP1. Thus one might speculate that
AQP1 deficiency inhibits the stimulating effect of NO on vascular
growth. There is no experimental evidence for such a pathway
at present but it could, in addition to the mechanism proposed
below, provide an explanation of the reduced capillary density
we find here in AQP1-deficient cardiac muscle.
Secondly, aside from the conduction of NO by AQP1,
aquaporin’s function as a water channel may provide another
explanation for an impaired angiogenesis. AQP1 is widely
accepted to play a central role in angiogenesis and, generally,
in cell migration (Papadopoulos et al., 2008). The molecular
mechanism of this role is not fully understood, but has been
speculated to involve AQP1-mediated water fluxes across the
membranes of the migrating cells (Papadopoulos et al., 2008).
Cell migration is essential for angiogenesis, as well as for
several other biological processes like wound healing, tumor
spread, and organ regeneration. As mentioned above, AQP1
is expressed in most blood capillaries, and it has been shown
during the last few years that endothelial AQP1 is involved in
angiogenesis in a multitude of tumors (Saadoun et al., 2005;
Yang et al., 2006; Otterbach et al., 2010; López-Campos et al.,
2011; Nicchia et al., 2013; Zou et al., 2013; Esteva-Font et al.,
2014). AQP1 is also involved in angiogenesis in other tissues
such as in heart tissue after myocardial infarction (Ran et al.,
2010), in neovascularization of the cirrhotic liver (Huebert
et al., 2010; Yokomori et al., 2011), and in tube formation
of human retinal vascular endothelial cells (Kaneko et al.,
2008). Thus, it seems well-established that AQP1 is essential
in capillary growth. If this occurs in the same way during
development of the heart, we can predict that lack of AQP1 will
impair capillarisation of heart tissue, which would also explain
the diminished capillarisation seen for the adult KO heart in
Table 1. Reduced capillarisation of cardiac muscle could be the
primary event that leads to all other abnormalities of AQP1-
KO hearts compiled in Table 1: It has been shown (Tirziu et al.,
2007) that growth of cardiomyocytes as well as of total heart
weight is regulated by capillary density. Stimulating capillary
growth caused cardiac hypertrophy. Vice versa, in the present
case inhibition of capillary growth by lack of AQP1 can be
expected to impair growth of the individual cardiomyocytes
as reported in Table 1. If the total number of fibers per heart
remains unaltered, this will lead to reduced wall thickness and
cardiac muscle mass. It is thus conceivable that by this chain
of events, lack of AQP1 during heart development causes the
reduced wall thickness and muscle mass we observe here. This
should lead to a reduced maximal stroke volume and maximal
cardiac output of the AQP1-deficient heart, which would limit
maximal physical performance of these mice. This cannot be
demonstrated under the conditions of the anesthetized mouse,
and other approaches than those used here will be necessary to
achieve this.
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